Compound Detail
CHEMBL4746275
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4746275 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MNTGVTWPXKMJCQ-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
458.6
MW (Da)
5.27
ALogP
7
HBA
2
HBD
92.7
PSA (Ų)
0.41
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 9.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 9.4 | 7.34 | 0.4 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK | IC50 | = | 0.4 | nM | 9.4 | Inhibition of recombinant human full-length N-terminal His6-tagged BTK expressed... | 32696648 |
| Tyrosine-protein kinase BTK | IC50 | = | 5300.0 | nM | 5.28 | Inhibition of BTK in human whole blood assessed as reduction in BTK phosphorylat... | 32696648 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32696648 | 10.1021/acs.jmedchem.0c00702 | Tyrosine-protein kinase BTK | 2 |
| 32696648 | 10.1021/acs.jmedchem.0c00702 | No relevant target | 2 |
Data from ChEMBL 36 via Core Engine